Early Phase 1 Type 1 Diabetes Trial, Recruiting NCT04449198 Sponsor: Augusta University Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Early Phase 1 Type 1 Diabetes Trial, Recruiting

NCT04449198
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men and women who have not yet gone through menopause
  • People of any racial background
  • People who have been diagnosed with insulin-dependent type 1 diabetes (for the patient group of the trial)

Who may not be able to join:

  • People who have been diagnosed with liver, heart, or kidney disease
  • People whose diabetes is not well controlled (based on a blood sugar marker called HbA1c being above 12%)
  • People who have diabetes-related complications, such as nerve damage (confirm with trial site for full list)
  • People with high blood pressure that remains above 140/90 even while on blood pressure medication
  • People who are currently pregnant
  • People who take medications that affect blood vessel function (confirm with trial site for specific medications)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Augusta University
Registry
ClinicalTrials.gov
Start date
14 October 2020
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in AUC for ET-1 + BQ-123; Skeletal Muscle Mitochondrial Function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov